Straumann® Mini Implant System
Mini Implant. Maximum trust.
Smiling, laughing and eating naturally add to a quality of life that every edentulous patient would love to maintain. Now you can provide edentulous patients presenting reduced horizontal bone availability with a immediate, less invasive*, removable fixation of their overdenture. You and your patients can rely on a trusted brand, premium quality and long-term scientific evidence. Less invasive* treatment plans, faster healing and less post-operative discomfort can help to overcome many patient doubts.
Roxolid® – Proven quality
Higher mechanical strength compared to titanium.1 The successful use of Roxolid® has been documented in numerous clinical trials with up to 5-year follow-ups.2 Lifetime Guarantee, our quality and longevity statement!
SLA® – Long-term scientific evidence
High and consistent survival rates.3–9 Very low prevalence of peri-implantitis.9 Average bone loss of 0.5 – 1 mm after 10 years (baseline defined as implant loading time).4-5
Learn more about SLA® >>>
Optiloc® – Durability & efficiency
Reduced maintenance. Excellent resistance to wear. Space-saving design.
Less invasive treatment plans (faster healing and less post-operative discomfort) can help to overcome many patient doubts.
*if GBR can be avoided
Your benefits by using
the Straumann® Mini Implant System
Increase patient acceptance for implant treatment by eliminating bone augmentation
Offer more quality of life to more edentulous patients due to more secure fit of the removable dentures
Differentiate your practice with new gold standard material Roxolid® and see an increased practice revenue stream
Trust in Mini Implants: Straumann® Lifetime Guarantee.
How does it work?
The Straumann® Mini Implant is placed and then immediately loaded with the removable denture. The procedure is minimally invasive1, which reduces level of discomfort for patients and reduces the healing time.
Featured stories on youTooth
1 Bernhard N et al., (2009). Forum Implantologicum 5(30).
3 Fischer K, Stenberg T.: Prospective 10-year cohort study based on a randomized controlled trial (RCT) on implant-supported full-arch maxillary prostheses. Part 1: sandblasted and acid-etched implants and mucosal tissue. Clin Implant Dent Relat Res. 2012 Dec;14(6):808-15.
4 van Velzen FJ, Ofec R, Schulten EA, Ten Bruggenkate CM,.10-year survival rate and the incidence of peri-implant disease of 374 titanium dental implants with a SLA surface: a prospective cohort study in 177 fully and partially edentulous patients. Clin Oral Implants Res. 2015 Oct;26(10):1121-8
5 Cochran DL, Jackson JM, Bernard JP, ten Bruggenkate CM, Buser D, Taylor TD, Weingart D, Schoolfield JD, Jones AA, Oates TW Jr. A 5-year prospective multicenter study of early loaded titanium implants with a sandblasted and acid-etched surface. Int J Oral Maxillofac Implants. 2011 Nov-Dec;26(6):1324-32.
6 Cochran D, Oates T, Morton D, Jones A, Buser D, Peters F. Clinical field trial examining an implant with a sand-blasted, acid-etched surface. J Periodontol. 2007 Jun;78(6):974-82.
7 Bornstein MM, Schmid B, Belser UC, Lussi A, Buser D. Early loading of non-submerged titanium implants with a sandblasted and acid-etched surface. 5-year results of a prospective study in partially edentulous patients. Clin Oral Implants Res. 2005 Dec;16(6):631-8.
8 Roccuzzo M1, Aglietta M, Bunino M, Bonino L. Early loading of sandblasted and acid-etched implants: a randomized-controlled double-blind split-mouth study. Five-year results. Clin Oral Implants Res. 2008 Feb;19(2):148-52.
9 Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Effectiveness of Implant Therapy Analyzed in a Swedish Population: Prevalence of Peri-implantitis. J Dent